Kogenate FS

antihemophilic factor (recombinant) for the treatment of Hemophilia A

Free Trial| EZ Log| Prescribing Information

Contact Us

Search

EZ-LOG

EXISTING USERS LOGIN EZ LOG LOGIN

Enroll Now to Use EZ-LOG... The interactive link for people with hemophilia A

Take control of hemophilia A therapy

EZ-LOG Web Diary is a safe, secure, password-protected system to help you stay on track with your hemophilia A treatment. EZ-LOG Web Diary is more than just an online diary. It is an effective way to get connected and stay connected to your healthcare providers for hemophilia A treatment monitoring between visits. EZ-LOG Web Diary is a free service available to all hemophilia A patients regardless of the factor product you use. Enroll today to experience the following benefits:

  • Storage and tracking of your infusion history that you can’t lose or misplace
  • Four helpful treatment reports to track your therapy and ongoing hemophilia A management
  • E-mail alerts that notify your factor provider of low inventory levels
  • 1-to-1 privacy-secured messaging so that you can communicate with hemophilia A treatment centers and home healthcare organizations
  • Optional text messaging to your mobile phone that keeps you up to date about important information regarding your therapy
  • Tracking to identify lot number of product

 

EZ-LOG Web Diary Allows You to Record and Track Treatment Wherever Internet Access Is Available

EZ-LOG Web Diary support is available Monday through Friday between 8:00 a.m. and 8:00 p.m. EST/EDT via phone at 800-732-4188 ext. 27 and by e-mail anytime at support@aheh.com.

For more information on EZ-LOG Web Diary, contact your local Bayer Hematology Account Executive.

IMPORTANT
EZ-LOG is not designed to replace your regular methods of communicating with your healthcare providers. It is especially important that you continue to contact your healthcare providers by phone or in person for any urgent medical events.

Although Bayer HealthCare Pharmaceuticals makes every reasonable effort to protect your data from interception, misuse, or alteration by third parties, you should be aware that there is always some risk involved in transmitting information over the Internet and that thieves could find a way to thwart our security systems.

Please consult with your healthcare provider to determine if Kogenate® FS is appropriate for you.

INDICATIONS & USAGE

Kogenate® FS, antihemophilic factor (recombinant), is a recombinant factor VIII treatment indicated for the control and prevention of bleeding episodes and peri-operative management in adults and children (0-16 years) with hemophilia A. Kogenate® FS is also indicated for routine prophylaxis to reduce the frequency of bleeding episodes and the risk of joint damage in children with hemophilia A with no preexisting joint damage.

IMPORTANT SAFETY INFORMATION

The most serious adverse reactions are systemic hypersensitivity reactions and the development of hightiter inhibitors necessitating alternative treatments to AHF. The most common adverse reactions observed in clinical trials were inhibitor formation in previously untreated or minimally treated patients, skin-associated hypersensitivity reactions, infusion site reactions, and central venous access device (CVAD) line-associated infections.

Kogenate® FS is contraindicated in patients who have manifested life-threatening immediate hypersensitivity reactions, including anaphylaxis, to the product or its components, including mouse or hamster proteins.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

For important risk and use information, please see the full prescribing information.

Prescribing Information | Privacy Policy | Terms of Use | Sitemap

© 2010 Bayer HealthCare Pharmaceuticals, Inc. All rights reserved.
BAYER, the Bayer Cross, and Kogenate FS are registered trademarks of Bayer HealthCare Pharmaceuticals.
BIO-SET is a trademark of Biodome SAS.

Kogenate FS Antihemophilic Factor (Recombinant) with BIO-SET Needleless Reconstitution System

Bayer HealthCare Pharmaceuticals